Tradestie Institutional Equity Comparison Engine

PVLA vs TVTX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PVLA Overall Edge

PVLA Captures Institutional Edge (3โ€“1 Pillars ยท 4โ€“6 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Palvella Therapeutics, Inc. Common Stock (PVLA) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while TVTX counters with relative strength in Valuation. Fundamentally, PVLA trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus TVTX at 9.3x Forward P/E and -3.1% operating margin (+36.2% YoY). In options structure, PVLA sits in CONSOLIDATION (2nd %ile IV; Dealer Gamma Walls on Pro) against TVTX sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner TVTX
PVLA N/M vs TVTX 9.3x Fwd P/E
Growth & Margin Winner PVLA
Op Margin 0.0% vs -3.1% ยท YoY +0.0% vs +36.2%
Momentum & Technical Winner PVLA
1Y +80.2% vs +47.2% ยท 52W Pos 68% vs 59%
Options & Structure Winner PVLA
CONSOLIDATION (2nd %ile IV) vs CONSOLIDATION (6th %ile IV)
PVLA NASDAQ
Palvella Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$145.03
-4.89% 1D
Market Cap $2.2B
1M Return +20.56%
1Y Return +80.16%
Forward P/E N/M
Unified AI Score
48.2 / 100 HOLD
Tech 35.0 Fund 53.0 Flow 67.0 Mom 60.0
TVTX NASDAQ
Travere Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$49.90
-1.48% 1D
Market Cap $4.9B
1M Return +0.6%
1Y Return +47.24%
Forward P/E 9.3x
Unified AI Score
60.4 / 100 BUY
Tech 47.0 Fund 58.0 Flow 64.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PVLA +80.16% TVTX +47.24% Spread: +32.92 pp (PVLA Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period PVLA Revenue TVTX Revenue PVLA Op. Margin TVTX Op. Margin Margin Edge
FY2018 $30M $160M -113.1% -48.7% TVTX
FY2019 $40M $180M -62.2% -78.3% PVLA
FY2020 $30M $200M -115.7% -88.8% TVTX
FY2021 $30M $130M -165.0% -151.3% TVTX
FY2022 $30M $110M -167.8% -292.2% PVLA
FY2023 $40M $150M -27.7% -267.2% PVLA
FY2024 N/A $230M N/A -138.9% TVTX
FY2025 N/A $490M N/A -12.8% TVTX

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PVLA (4) vs TVTX (6)
Institutional Metric PVLA TVTX Criterion Row Winner
Market Capitalization Scale $2.2B $4.9B Larger Scale TVTX
Trailing P/E Ratio Valuation N/M 25.8x Lower Multiple TVTX
Forward P/E Ratio Valuation N/M 9.3x Lower Multiple TVTX
Revenue Growth (YoY) Growth +0.0% +36.2% Higher Growth TVTX
Operating Margin (TTM) Profitability 0.0% -3.1% Higher Margin PVLA
Net Profit Margin Profitability 0.0% -18.7% Higher Margin PVLA
Return on Equity (ROE) Capital Efficiency -63.4% -321.2% Higher ROE PVLA
52-Week Range Position Momentum 68% ($72โ€“$180) 59% ($23โ€“$69) Stronger Trend PVLA
Beta / 30D Volatility Risk Regime 1.66ฮฒ ยท 75% Vol 1.39ฮฒ ยท 44% Vol Lower Realized Risk TVTX
Unified Institutional Score Composite Signal 48.2 / 100 (HOLD) 60.4 / 100 (BUY) Higher Composite TVTX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PVLA vs TVTX Buy Guide
PVLA CONSOLIDATION
70d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 2nd %ile
IV Regime Compressed (<25th %ile)
Live PVLA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
TVTX CONSOLIDATION
101d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live TVTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PVLA nor TVTX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.